Works by Agha, Mounzer

Results: 37

Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.

Published in:

American Journal of Hematology, 2024, v. 99, n. 3, p. 380, doi. 10.1002/ajh.27212

By:

Im, Annie;
Quann, Kevin;
Agha, Mounzer;
Raptis, Anastasios;
Redner, Robert L.;
Hou, Jing‐Zhou;
Farah, Rafic;
Dorritie, Kathleen A.;
Sehgal, Alison R.;
Normolle, Daniel;
Bovbjerg, Dana H.;
Aggarwal, Nidhi;
Herman, James;
Lontos, Konstantinos;
Boyiadzis, Michael

Publication type:

Article

FGFR1-associated myeloid neoplasm with increased mast cells.

Published in:

British Journal of Haematology, 2017, v. 177, n. 2, p. 172, doi. 10.1111/bjh.14533

By:

Roth, Christine G.;
Agha, Mounzer

Publication type:

Article

Patient and family caregiver dyadic adherence to the allogeneic hematopoietic cell transplantation medical regimen.

Published in:

2018

By:

Posluszny, Donna M.;
Bovbjerg, Dana H.;
Agha, Mounzer E.;
Hou, Jing‐Zhou;
Raptis, Anastasios;
Boyiadzis, Michael M.;
Dunbar‐Jacob, Jacqueline;
Schulz, Richard;
Dew, Mary Amanda;
Hou, Jing-Zhou;
Dunbar-Jacob, Jacqueline

Publication type:

journal article

S202: CARTITUDE-1 FINAL RESULTS: PHASE 1B/2 STUDY OF CILTACABTAGENE AUTOLEUCEL IN HEAVILY PRETREATED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA.

Published in:

2023

By:

Munshi, Nikhil;
Martin, Tom;
Usmani, Saad Z;
Berdeja, Jesus;
Jakubowiak, Andrzej;
Agha, Mounzer;
Cohen, Adam D;
Deol, Abhinav;
Htut, Myo;
Lesokhin, Alexander;
Lin, Yi;
O'donnell, Elizabeth;
Jackson, Carolyn C;
Yeh, Tzu-Min;
Banerjee, Arnob;
Zudaire, Enrique;
Madduri, Deepu;
Delcorral, Christopher;
Pacaud, Lida;
Jagannath, Sundar

Publication type:

Abstract

Correction: Mu heavy chain disease with MYD88 L265P mutation: An unusual manifestation of lymphoplasmacytic lymphoma.

Published in:

2022

By:

Baloda, Vandana;
Wheeler, Sarah E.;
Murray, David L.;
Kohlhagen, Mindy C.;
Vos, Jeffrey A.;
Yatsenko, Svetlana A.;
Agha, Mounzer E.;
Djokic, Miroslav;
Swerdlow, Steven H.;
Bailey, Nathanael G.

Publication type:

Correction Notice

Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma.

Published in:

Diagnostic Pathology, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13000-022-01244-1

By:

Baloda, Vandana;
Wheeler, Sarah E.;
Murray, David L.;
Kohlhagen, Mindy C.;
VosUPMC, Jeffrey A.;
Yatsenko, Svetlana A.;
Agha, Mounzer E.;
Djokic, Miroslav;
Swerdlow, Steven H.;
Bailey, Nathanael G.

Publication type:

Article

Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation.

Published in:

Clinical Transplantation, 2017, v. 31, n. 9, p. n/a, doi. 10.1111/ctr.13052

By:

Lontos, Konstantinos;
Agha, Mounzer;
Raptis, Anastasios;
Hou, Jing‐Zhou;
Farah, Rafic;
Redner, Robert L.;
Im, Annie;
Dorritie, Kathleen A.;
Sehgal, Alison;
Rossetti, James;
Saul, Melissa;
Gooding, William E.;
Humar, Abhinav;
Boyiadzis, Michael

Publication type:

Article

Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: A case series.

Published in:

Journal of Clinical Apheresis, 1996, v. 11, n. 4, p. 176, doi. 10.1002/(SICI)1098-1101(1996)11:4<176::AID-JCA2>3.0.CO;2-8

By:

Dua, Aashish;
Zeigler, Zella R.;
Shadduck, Richard K.;
Nath, Rajneesh;
Andrews, D. Frank;
Agha, Mounzer

Publication type:

Article

CD-19 CART therapy and orthostatic hypotension: a single center retrospective cohort study.

Published in:

Cardio-Oncology, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40959-022-00132-3

By:

Patel, Ashish;
Levenson, Joshua;
Huang, Ziyu;
Agha, Mounzer;
Dorritie, Kathleen

Publication type:

Article

A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.

Published in:

Leukemia & Lymphoma, 2018, v. 59, n. 11, p. 2595, doi. 10.1080/10428194.2018.1443330

By:

Redner, Robert L.;
Beumer, Jan H.;
Kropf, Patricia;
Agha, Mounzer;
Boyiadzis, Michael;
Dorritie, Kathleen;
Farah, Rafic;
Hou, Jing-Zhao;
Im, Annie;
Lim, Seah H.;
Raptis, Anastasios;
Sehgal, Alison;
Christner, Susan M.;
Normolle, Daniel;
Johnson, Daniel E.

Publication type:

Article

De novo acute myeloid leukemia with Philadelphia chromosome ( BCR--ABL) and inversion 16 ( CBFB--MYH11): report of two cases and review of the literature.

Published in:

Leukemia & Lymphoma, 2011, v. 52, n. 3, p. 531, doi. 10.3109/10428194.2010.538941

By:

Roth, Christine G.;
Contis, Lydia;
Gupta, Saurabh;
Agha, Mounzer;
Safyan, Eric

Publication type:

Article

Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin.

Published in:

Leukemia & Lymphoma, 2009, v. 50, n. 11, p. 1848, doi. 10.3109/10428190903216788

By:

McHayleh, Wassim;
Sehgal, Rajesh;
Redner, Robert L.;
Raptis, Anastasios;
Agha, Mounzer;
Natale, James;
Luong, The Minh;
Schlesselman, James J.;
Foon, Kennteh A.;
Boyiadzis, Michael

Publication type:

Article

Hypomethylating Agents for Relapse after Allogeneic Hematopoietic Cell Transplantation in Myeloid Malignancies: A Case Series and Review of the Literature.

Published in:

Acta Haematologica, 2016, v. 135, n. 4, p. 232, doi. 10.1159/000444118

By:

Im, annie;
Raptis, anastasios;
Hou, Jing-Zhou;
Tompkins, Cheryl;
Winfield, Melissa;
Guay, Mary;
Boyiadzis, Michael;
agha, Mounzer

Publication type:

Article

Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission.

Published in:

Oncology Research, 2020, v. 28, n. 7/8, p. 811, doi. 10.3727/096504020X15965357399750

By:

Patel, Arisha;
Agha, Mounzer;
Raptis, Anastasios;
Hou, Jing-Zhou;
Farah, Rafic;
Redner, Robert L.;
Im, Annie;
Dorritie, Kathleen A.;
Sehgal, Alison;
Rossetti, James;
Saul, Melissa;
Normolle, Daniel;
Lontos, Konstantinos;
Boyiadzis, Michael

Publication type:

Article

Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant.

Published in:

American Journal of Hematology, 2016, v. 91, n. 3, p. 291, doi. 10.1002/ajh.24263

By:

Agha, Aya;
Sehgal, Alison;
Lim, Matthew J.;
Weber, David;
Hou, Jing-Zhou;
Farah, Rafic;
Raptis, Anastasios;
Im, Annie;
Dorritie, Kathleen;
Marks, Stanley;
Agha, Mounzer;
Lim, Seah H.

Publication type:

Article

Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapy.

Published in:

American Journal of Hematology, 2015, v. 90, n. 8, p. 715, doi. 10.1002/ajh.24062

By:

Lim, Sara J.;
Lim, Matthew J.;
Raptis, Anastasios;
Hou, Jing-Zhou;
Farah, Rafic;
Marks, Stanley M.;
Im, Annie;
Dorritie, Kathleen;
Sehgal, Alison;
Agha, Mounzer;
Felgar, Raymond;
Lim, Seah H.

Publication type:

Article

Salvage of Donor Graft with Decitabine and Maintenance Post Allogeneic Stem Cell Transplantation in Myelodysplastic/Myeloproliferative Disease: A Case Report.

Published in:

2009

By:

Raptis, Anastasios;
Agha, Mounzer;
Shah, Megha

Publication type:

Case Study

Gemtuzumab Ozogamicin as First-Line Treatment in Patients Aged 70 Years or Older With Acute Myeloid Leukemia.

Published in:

Cancer (0008543X), 2010, v. 116, n. 12, p. 3001, doi. 10.1002/cncr.25078

By:

McHayleh, Wassim;
Foon, Kenneth;
Redner, Robert;
Sehgal, Rajesh;
Raptis, Anastasios;
Agha, Mounzer;
The Minh Luong;
Schlesselman, James J.;
Boyiadzis, Michael

Publication type:

Article

Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry.

Published in:

Cancers, 2021, v. 13, n. 23, p. 5996, doi. 10.3390/cancers13235996

By:

Merz, Maximilian;
Goldschmidt, Hartmut;
Hari, Parameswaran;
Agha, Mounzer;
Diels, Joris;
Ghilotti, Francesca;
Perualila, Nolen J.;
Cabrieto, Jedelyn;
Haefliger, Benjamin;
Sliwka, Henrik;
Schecter, Jordan M.;
Jackson, Carolyn C.;
Olyslager, Yunsi;
Akram, Muhammad;
Nesheiwat, Tonia;
Kellermann, Lenka;
Jagannath, Sundar

Publication type:

Article

Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients.

Published in:

Clinical Infectious Diseases, 2023, v. 77, n. 5, p. 696, doi. 10.1093/cid/ciad233

By:

Haidar, Ghady;
Jacobs, Jana L;
Kramer, Kailey Hughes;
Naqvi, Asma;
Heaps, Amy;
Parikh, Urvi;
McCormick, Kevin D;
Sobolewski, Michele D;
Agha, Mounzer;
Bogdanovich, Tatiana;
Bushunow, Vasilii;
Farah, Rafic;
Hensley, Matthew;
Hsu, Yen-Michael S;
Johnson, Bruce;
Klamar-Blain, Cynthia;
Kozar, Jennifer;
Lendermon, Elizabeth;
Macatangay, Bernard J C;
Marino, Christopher C

Publication type:

Article

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS).

Published in:

Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e630, doi. 10.1093/cid/ciac103

By:

Haidar, Ghady;
Agha, Mounzer;
Bilderback, Andrew;
Lukanski, Amy;
Linstrum, Kelsey;
Troyan, Rachel;
Rothenberger, Scott;
McMahon, Deborah K;
Crandall, Melissa D;
Sobolewksi, Michele D;
Enick, P Nathan;
Jacobs, Jana L;
Collins, Kevin;
Klamar-Blain, Cynthia;
Macatangay, Bernard J C;
Parikh, Urvi M;
Heaps, Amy;
Coughenour, Lindsay;
Schwartz, Marc B;
Dueker, Jeffrey M

Publication type:

Article

Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy.

Published in:

International Journal of Hematology, 2012, v. 96, n. 6, p. 743, doi. 10.1007/s12185-012-1192-9

By:

McLaughlin, Brian;
Im, Annie;
Raptis, Anastasios;
Agha, Mounzer;
Hou, Jing-Zhou;
Redner, Robert;
Duggal, Shrina;
Lin, Yan;
Smith, Clay;
Boyiadzis, Michael

Publication type:

Article

Persistent cytopenias after anti-BCMA CAR T-cell therapy are associated with reduced hematopoietic activity in posttreatment bone marrows.

Published in:

American Journal of Clinical Pathology, 2024, v. 162, n. 6, p. 641, doi. 10.1093/ajcp/aqae083

By:

Patwardhan, Pranav Pramod;
Franz, Joseph;
Agha, Mounzer;
Rea, Bryan

Publication type:

Article

Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant.

Published in:

European Journal of Haematology, 2016, v. 96, n. 1, p. 55, doi. 10.1111/ejh.12547

By:

Lim, Sara J.;
Lim, Matthew J.;
Raptis, Anastasios;
Hou, Jing‐Zhou;
Farah, Rafic;
Marks, Stanley;
Im, Annie;
Dorritie, Kathleen;
Sehgal, Alison;
Agha, Mounzer;
Lim, Seah H.

Publication type:

Article

Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.

Published in:

2018

By:

Lim, Matthew J.;
Agha, Aya;
Im, Annie;
Raptis, Anastasios;
Hou, Jing Z.;
Boyiadzis, Michael;
Sehgal, Alison R.;
Redner, Robert L.;
Dorritie, Kathleen;
Marks, Stanley S.;
Agha, Mounzer E.;
Lim, Seah H.

Publication type:

Letter

Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 12, p. 882, doi. 10.1016/j.clml.2023.08.012

By:

Htut, Myo;
Dhakal, Binod;
Cohen, Adam D.;
Martin, Thomas;
Berdeja, Jesus G.;
Usmani, Saad Z.;
Agha, Mounzer;
Jackson, Carolyn C.;
Madduri, Deepu;
Deraedt, William;
Zudaire, Enrique;
Yeh, Tzu-min;
Xu, Xiaoying;
Pacaud, Lida;
Akram, Muhammad;
Jagannath, Sundar

Publication type:

Article

OAB-024: Updated results from CARTITUDE-1: Ciltacabtagene autoleucel, a B-cell maturation antigen–directed chimeric antigen receptor T (CAR-T) cell therapy, in relapsed/refractory multiple myeloma (RRMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S15, doi. 10.1016/S2152-2650(21)02098-X

By:

Jagannath, Sundar;
Berdeja, Jesus G.;
Jakubowiak, Andrzej;
Agha, Mounzer;
Cohen, Adam;
Madduri, Deepu;
Hari, Parameswaran;
Yeh, Tzu-Min;
Olyslager, Yunsi;
Banerjee, Arnob;
Jackson, Carolyn C.;
Allred, Alicia;
Zudaire, Enrique;
Deraedt, William;
Wu, Xiaoling;
Pacaud, Lida;
Akram, Muhammad;
Lin, Yi;
Martin, Thomas;
Usmani, Saad Z.

Publication type:

Article

OAB-023: Efficacy and safety of ciltacabtagene autoleucel, a BCMA-directed CAR-T cell therapy, in patients with progressive multiple myeloma after 1–3 prior lines of therapy: Initial results from CARTITUDE-2.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S15, doi. 10.1016/S2152-2650(21)02097-8

By:

Cohen, Adam;
Agha, Mounzer;
Madduri, Deepu;
Cohen, Yael;
Delforge, Michel;
Hillengass, Jens;
Goldschmidt, Hartmut;
Weisel, Katja;
Raab, Marc-Steffen;
Scheid, Christoph;
Schecter, Jordan M.;
Braganca, Kevin C. De;
Varsos, Helen;
Wang, Liwei;
Vogel, Martin;
Carrasco-Alfonso, Marlene;
Akram, Muhammad;
Wu, Xiaoling;
Nesheiwat, Tonia;
Einsele, Hermann

Publication type:

Article

MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S422, doi. 10.1016/S2152-2650(21)01946-7

By:

Usmani, Saad Z.;
Berdeja, Jesus G.;
Madduri, Deepu;
Jakubowiak, Andrzej;
Agha, Mounzer;
Cohen, Adam D.;
Hari, Parameswaran;
Yeh, Tzu-Min;
Olyslager, Yunsi;
Banerjee, Arnob;
Jackson, Carolyn C;
Allred, Alicia;
Zudaire, Enrique;
Deraedt, William;
Wu, Xiaoling;
Carrasco-Alfonso, Marlene J.;
Akram, Muhammad;
Lin, Yi;
Martin, Thomas;
Jagannath, Sundar

Publication type:

Article

Poster: MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S249, doi. 10.1016/S2152-2650(21)01569-X

By:

Usmani, Saad Z.;
Berdeja, Jesus G.;
Madduri, Deepu;
Jakubowiak, Andrzej;
Agha, Mounzer;
Cohen, Adam D.;
Hari, Parameswaran;
Yeh, Tzu-Min;
Olyslager, Yunsi;
Banerjee, Arnob;
Jackson, Carolyn C;
Allred, Alicia;
Zudaire, Enrique;
Deraedt, William;
Wu, Xiaoling;
Carrasco-Alfonso, Marlene J.;
Akram, Muhammad;
Lin, Yi;
Martin, Thomas;
Jagannath, Sundar

Publication type:

Article

Oral Abstract: MM-119: Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S202, doi. 10.1016/S2152-2650(21)01275-1

By:

Usmani, Saad Z.;
Berdeja, Jesus G.;
Madduri, Deepu;
Jakubowiak, Andrzej;
Agha, Mounzer;
Cohen, Adam D.;
Hari, Parameswaran;
Yeh, Tzu-Min;
Olyslager, Yunsi;
Banerjee, Arnob;
Jackson, Carolyn C;
Allred, Alicia;
Zudaire, Enrique;
Deraedt, William;
Wu, Xiaoling;
Carrasco-Alfonso, Marlene J.;
Akram, Muhammad;
Yi Lin;
Martin, Thomas;
Jagannath, Sundar

Publication type:

Article

A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.

Published in:

Supportive Care in Cancer, 2022, v. 30, n. 2, p. 1673, doi. 10.1007/s00520-021-06339-x

By:

McKeown, Christi;
Ricciuti, Asha;
Agha, Mounzer;
Raptis, Anastasios;
Hou, Jing-Zhou;
Farah, Rafic;
Redner, Robert L.;
Im, Annie;
Dorritie, Kathleen A.;
Sehgal, Alison;
Rossetti, James;
Lontos, Konstantinos;
Bovbjerg, Dana H.;
Normolle, Daniel;
Boyiadzis, Michael

Publication type:

Article

Correlates of anxiety and depression symptoms among patients and their family caregivers prior to allogeneic hematopoietic cell transplant for hematological malignancies.

Published in:

2019

By:

Posluszny, Donna M.;
Bovbjerg, Dana H.;
Syrjala, Karen L.;
Agha, Mounzer;
Dew, Mary Amanda

Publication type:

journal article

Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era.

Published in:

Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab353

By:

Agha, Mounzer E;
Blake, Maggie;
Chilleo, Charles;
Wells, Alan;
Haidar, Ghady

Publication type:

Article

Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.

Published in:

Leukemia & Lymphoma, 2023, v. 64, n. 3, p. 750, doi. 10.1080/10428194.2023.2172981

By:

Lontos, Konstantinos;
Tsagianni, Anastasia;
Agha, Mounzer;
Raptis, Anastasios;
Hou, Jing-Zhou;
Farah, Rafic;
Redner, Robert L.;
Im, Annie;
Dorritie, Kathleen A.;
Sehgal, Alison;
Rossetti, James;
Aggarwal, Nidhi;
Saul, Melissa;
Boyiadzis, Michael;
Bailey, Nathanael G.

Publication type:

Article

A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.

Published in:

Leukemia & Lymphoma, 2022, v. 63, n. 13, p. 3257, doi. 10.1080/10428194.2022.2118532

By:

Lontos, Konstantinos;
Tsagianni, Anastasia;
Agha, Mounzer;
Raptis, Anastasios;
Hou, Jing-Zhou;
Farah, Rafic;
Redner, Robert L.;
Im, Annie;
Dorritie, Kathleen A.;
Sehgal, Alison;
Rossetti, James;
Aggarwal, Nidhi;
Saul, Melissa;
Gooding, William;
Boyiadzis, Michael

Publication type:

Article

Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy.

Published in:

2011

By:

Boyiadzis, Michael;
Redner, Robert L.;
Raptis, Anastasios;
Jing-Zhou Hou;
Agha, Mounzer;
Foon, Kenneth A.;
Hou, Jing-Zhou

Publication type:

clinical trial